Substitutes for Glibcla MP 5mg/500mg/15mg Tablet
Composition: Glibenclamide 5mg + Pioglitazone 15mg + Metformin 500mg
Glibcla MP 5mg/500mg/15mg Tablet is out of stock right now
Good news — 2 medicines with the same composition are listed below and can be ordered instead.
You're viewing
Glibcla MP 5mg/500mg/15mg Tablet
RxFibovil Pharmaceuticals Pvt Ltd
₹95 Out of stock
View details Same molecule
2Same active ingredient(s) but a different strength or form — check the strength matches your prescription.
About these molecules
Glibenclamide5mg
Full details →Glibenclamide is an oral hypoglycemic agent used to treat type 2 diabetes mellitus. It works by stimulating insulin secretion from the pancreas, thereby lowering blood glucose levels. Glibenclamide is clinically significant for managing diabetes and preventing complications associated with high blood sugar. In summary, glibenclamide is essential for controlling blood sugar levels in diabetic patients.
Pioglitazone15mg
Full details →Pioglitazone is an antidiabetic medication used to treat type 2 diabetes. It works by improving insulin sensitivity and regulating blood sugar levels. Pioglitazone is effective in managing diabetes. In summary, Pioglitazone is beneficial for treating type 2 diabetes.
Metformin500mg
Full details →Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
Why a generic substitute?
Same active ingredient
A substitute has the exact same salt(s) — so it works the same way as the brand.
Often much cheaper
Generics can cost a fraction of the branded price for the identical molecule.
Quality-regulated
All medicines we list are from licensed sellers and meet the same standards.
Substitutes share the same active ingredients, but always confirm the strength and form with your doctor or pharmacist before switching — especially for chronic, prescription or narrow-therapeutic-index medicines.
